Michael B. Hoffman - 20 Dec 2024 Form 3 Insider Report for Translational Development Acquisition Corp. (TDAC)

Role
Chief Executive Officer, Director
Signature
/s/ Michael B. Hoffman
Issuer symbol
TDAC
Transactions as of
20 Dec 2024
Net transactions value
$0
Form type
3
Filing time
20 Dec 2024, 18:54:41 UTC
Previous filing
22 Nov 2023
Next filing
02 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TDAC Class B Ordinary Shares 20 Dec 2024 Class A Ordinary Shares 4,657,500 See Footnote F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As described in the issuer's registration statement on Form S-1 (File No. 333-282763) under the heading "Description of Securities - Ordinary Shares," the Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation issuer's initial business combination, on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and certain anti-dilution rights and has no expiration date.
F2 Includes up to 607,500 shares subject to forfeiture by TDAC Partners LLC (the "Sponsor") depending on the extent to which the underwriters' option to purchase additional units is exercised.
F3 The Reporting Person is a managing member of the Sponsor and as a result may be deemed to beneficially own the securities held of record by the Sponsor. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.